GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » Cyclically Adjusted PS Ratio

BioCorRx (BioCorRx) Cyclically Adjusted PS Ratio : 2.50 (As of Apr. 28, 2024)


View and export this data going back to 2009. Start your Free Trial

What is BioCorRx Cyclically Adjusted PS Ratio?

As of today (2024-04-28), BioCorRx's current share price is $0.75. BioCorRx's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $0.30. BioCorRx's Cyclically Adjusted PS Ratio for today is 2.50.

The historical rank and industry rank for BioCorRx's Cyclically Adjusted PS Ratio or its related term are showing as below:

BICX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.48   Med: 5.47   Max: 30.72
Current: 2.48

During the past years, BioCorRx's highest Cyclically Adjusted PS Ratio was 30.72. The lowest was 1.48. And the median was 5.47.

BICX's Cyclically Adjusted PS Ratio is ranked worse than
83.69% of 331 companies
in the Healthcare Providers & Services industry
Industry Median: 1.18 vs BICX: 2.48

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BioCorRx's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.002. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.30 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


BioCorRx Cyclically Adjusted PS Ratio Historical Data

The historical data trend for BioCorRx's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx Cyclically Adjusted PS Ratio Chart

BioCorRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.93 1.50 9.73 2.63 2.58

BioCorRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.63 5.30 6.07 6.90 2.58

Competitive Comparison of BioCorRx's Cyclically Adjusted PS Ratio

For the Medical Care Facilities subindustry, BioCorRx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCorRx's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioCorRx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BioCorRx's Cyclically Adjusted PS Ratio falls into.



BioCorRx Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

BioCorRx's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.75/0.3
=2.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCorRx's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, BioCorRx's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.002/129.4194*129.4194
=0.002

Current CPI (Dec. 2023) = 129.4194.

BioCorRx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.102 99.695 0.132
201406 0.168 100.560 0.216
201409 0.302 100.428 0.389
201412 0.252 99.070 0.329
201503 0.184 99.621 0.239
201506 0.302 100.684 0.388
201509 0.075 100.392 0.097
201512 0.045 99.792 0.058
201603 0.139 100.470 0.179
201606 0.114 101.688 0.145
201609 0.100 101.861 0.127
201612 0.064 101.863 0.081
201703 0.066 102.862 0.083
201706 0.036 103.349 0.045
201709 0.061 104.136 0.076
201712 0.068 104.011 0.085
201803 0.060 105.290 0.074
201806 0.040 106.317 0.049
201809 0.032 106.507 0.039
201812 0.020 105.998 0.024
201903 0.025 107.251 0.030
201906 0.022 108.070 0.026
201909 0.015 108.329 0.018
201912 0.012 108.420 0.014
202003 0.007 108.902 0.008
202006 0.006 108.767 0.007
202009 0.006 109.815 0.007
202012 0.004 109.897 0.005
202103 0.002 111.754 0.002
202106 0.002 114.631 0.002
202109 0.001 115.734 0.001
202112 0.002 117.630 0.002
202203 0.003 121.301 0.003
202206 0.002 125.017 0.002
202209 0.013 125.227 0.013
202212 0.011 125.222 0.011
202303 0.005 127.348 0.005
202306 0.002 128.729 0.002
202309 0.001 129.860 0.001
202312 0.002 129.419 0.002

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioCorRx  (OTCPK:BICX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


BioCorRx Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of BioCorRx's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioCorRx (BioCorRx) Business Description

Traded in Other Exchanges
N/A
Address
2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806
BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication-assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.
Executives
Louis C. Lucido director 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan director, 10 percent owner 333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy director 5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola director 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch officer: Vice President of Operations 10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry director, officer: Chief Executive Officer 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier director 13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix director, officer: Chief Financial Officer 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade director, officer: Chief Executive Officer PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr director, officer: President 13231 SANDHURST PLACE, SANTA ANA CA 92705